Management of Comorbidities in Diabetics With Renal Cell Carcinoma: Past Utilization and Current Outcomes

Conclusion: Reinforcing guidelines compliance for hyperlipidemia management in patients with DM may provide a considerable cancer benefit if diagnosed with RCC. Studies evaluating the need for cholesterol-lowering pharmacotherapy in guidelines-noncompliant DM cases upon RCC diagnosis are currently needed.
Source: Journal of Pharmacy Practice - Category: Drugs & Pharmacology Authors: Tags: Research Articles Source Type: research